Serum Levels of Vasoactive Intestinal Peptide as a Prognostic Marker in Early Arthritis

Por Martínez, Carmen, Ortiz, Ana M., Juarranz, Yasmina, Lamana, Amalia, Seoane, Iria V., Leceta, Javier, García-Vicuña, Rosario, Gomariz, Rosa P., González-Álvaro, Isidoro
Publicado em 2014

Clinical Relevance of VPAC1 Receptor Expression in Early Arthritis: Association with IL-6 and Disease Activity

Por Seoane, Iria V., Ortiz, Ana M., Piris, Lorena, Lamana, Amalia, Juarranz, Yasmina, García-Vicuña, Rosario, González-Álvaro, Isidoro, Gomariz, Rosa P., Martínez, Carmen
Publicado no PLoS One (2016)

Vasoactive intestinal peptide gene polymorphisms, associated with its serum levels, predict treatment requirements in early rheumatoid arthritis

Por Seoane, Iria V., Martínez, Carmen, García-Vicuña, Rosario, Ortiz, Ana M., Juarranz, Yasmina, Talayero, Vanessa C., González-Álvaro, Isidoro, Gomariz, Rosa P., Lamana, Amalia
Publicado no Sci Rep (2018)

Vasoactive Intestinal Peptide in Early Spondyloarthritis: Low Serum Levels as a Potential Biomarker for Disease Severity

Por Seoane, Iria V., Tomero, Eva, Martínez, Carmen, Garcia-Vicuña, Rosario, Juarranz, Yasmina, Lamana, Amalia, Ocón, Elena, Ortiz, Ana M., Gómez-León, Nieves, González-Álvaro, Isidoro, Gomariz, Rosa P.
Publicado no J Mol Neurosci (2015)